newsfilter
← Latest News
GlobeNewswire·

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), a U.S.-based, end-to-end commercial biopharmaceutical company